Cannabis Hyperemesis Syndrome in Youth: A Narrative Review Highlights Clinical Gaps and Public Health Urgency
Cannabis hyperemesis syndrome youth review reveals clinical gaps in understanding this cyclical vomiting condition linked to chronic cannabis use. Youth are disproportionately affected by this syndrome, which remains under-recognized. This review…
CBD in Childhood Epilepsy: What the Evidence Actually Shows
Several randomized controlled trials demonstrate cannabidiol pediatric epilepsy dosing reduces seizures in syndromes like Lennox-Gastaut and Dravet. This review summarizes dosing, drug interactions, and safety monitoring for cannabidiol in pediatric…
Cannabis for Nerve Pain: Mixed Evidence From 22 Trials, No Clear Winners Yet
Neuropathic pain cannabis treatment shows promise but remains inconclusive due to study limitations. Trials reveal mixed evidence with no definitive winners yet. Careful dosing and further research are essential for clinical guidance.
What the Evidence Really Says About CBD for Children With Epilepsy
This 2025 review highlights CBD pediatric epilepsy drug interactions and their impact on seizure management in children. Pharmaceutical-grade CBD shows meaningful seizure reduction in drug-resistant epilepsy. Careful monitoring and dosing are essential…
Cannabis Hyperemesis Syndrome in Young People: What Clinicians and Parents Need to Know
Cannabis hyperemesis syndrome clinical review highlights severe vomiting and nausea linked to cannabis use in young people. This condition often leads to misdiagnosis and delayed treatment. Understanding clinical phases and symptom relief is crucial for…
Can Mouth-Dissolving Films and Gels Solve Cannabis Medicine’s Bioavailability Problem?
Oral mucosal cannabinoid bioavailability offers a promising alternative to traditional oral ingestion by bypassing first-pass metabolism. Films and gels designed for transmucosal absorption can enhance cannabinoid delivery. This review examines the…
CBD for Childhood Epilepsy: What the Evidence Actually Shows
A 2025 clinical update highlights cannabidiol pediatric epilepsy evidence showing meaningful seizure reduction in children with drug-resistant epilepsy. The review emphasizes dosing protocols and safety monitoring. Cannabidiol pediatric epilepsy…
Most Primary Care Doctors Feel Unprepared to Advise Patients on Medical Cannabis—Especially for Older Adults
Primary care physicians cannabis counseling remains a challenge, especially for older adults. Most physicians feel unprepared to advise patients on medical cannabis safely. This gap highlights the urgent need for specialized education in cannabis use…
Can Epigenetic Therapies Break the Vicious Cycle Between Gum Disease and Diabetes?
Periodontitis diabetes epigenetics reveal shared molecular pathways worsening both diseases. This 2025 narrative review explores CBD and metformin as potential epigenetic modulators. Evidence remains preclinical with no clinical trial support yet.
Primary Care Doctors’ Gaps in Medical Cannabis Counseling for Older Adults
Medical cannabis counseling gaps exist among many primary care doctors, especially regarding older adults. Most physicians feel unprepared to advise patients on cannabis use safely. This highlights the urgent need for improved physician training in…
